MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by LivaNova PLC

< Previous 1 2 3 Next >
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Reports Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Announce Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Board Appoints Brooke Story as a New Director
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Reports Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Announce Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Elects Peter Wilver to Board of Directors
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present at the Goldman Sachs Global Healthcare Conference
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Reports First-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Announce First-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Reports Fourth-Quarter and Full-Year 2021 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Comments on Decision by Court of Appeal of Milan
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present at the 2021 Stifel and Jefferies Healthcare Conferences
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Announces 2021 Virtual Investor Day
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Reports Third Quarter 2021 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Host Conference Call for Third Quarter 2021 Results
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova to Present at the Baird 2021 Global Healthcare Conference
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Prices Offering of Ordinary Shares
From LivaNova PLC
Via Business Wire
Tickers LIVN
LivaNova Announces Offering of Ordinary Shares
From LivaNova PLC
Via Business Wire
Tickers LIVN
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story